Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipo-Flavonoid is a leading consumer healthcare brand specializing in over-the-counter dietary supplements for ear health, specifically targeting tinnitus (ringing in the ears). The product line was originally developed by an otolaryngologist in the 1960s and centers on a proprietary blend of eriodictyol glycoside, a bioflavonoid derived from lemon, alongside essential B-vitamins and vitamin C. These components are formulated to improve microcirculation within the inner ear, providing relief for symptoms associated with Meniere's disease and auditory sensitivity. Currently owned by Bridges Consumer Healthcare, the brand is widely recognized as the top-recommended supplement by ear, nose, and throat (ENT) specialists. The company's portfolio includes various formulations such as Lipo-Flavonoid Plus and Lipo-Flavonoid Night to address different patient needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipo Flavonoid.